Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A

Biochemical Pharmacology
M ChibaJ H Lin

Abstract

The metabolism of indinavir, a human immune deficiency virus (HIV) protease inhibitor, has been characterized extensively in rats and humans. All oxidative metabolites found in vivo were formed when indinavir was incubated with NADPH-fortified hepatic and intestinal microsomes obtained from rats and humans. In vitro kinetic studies revealed that Vmax/Km values (microL/min/mg protein) in rat and human liver microsomes were approximately 8- and 2-fold greater than those in the intestinal microsomes of the corresponding species (55.8 and 6.7 for the liver and intestine, respectively, in rats; 16.5 and 7.7 for the liver and intestine, respectively, in humans). However, when Vmax/Km was scaled up to intrinsic clearance (mL/min/kg body weight), hepatic intrinsic clearance was much greater than the intestinal clearance by 50- to 200-fold. These results suggest that the liver plays a much greater role in first-pass metabolism of indinavir than the intestine in both species. Consistently, ketoconazole, a selective inhibitor for CYP3A, and an anti-rat CYP3A1 antibody strongly inhibited hepatic and intestinal metabolism of indinavir in both rats and humans, suggesting the involvement of CYP3A isoforms in both organs. Oral treatment of rat...Continue Reading

References

Jan 1, 1991·Critical Reviews in Toxicology·L S Kaminsky, M J Fasco
Jul 1, 1991·Chemical Research in Toxicology·F P Guengerich, T Shimada
Oct 1, 1983·Journal of Pharmaceutical Sciences·L E Gerlowski, R K Jain
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·J P VaccaE Roth

❮ Previous
Next ❯

Citations

Apr 29, 1998·Journal of Clinical Pharmacology·L L von MoltkeR I Shader
Aug 13, 2013·International Journal of Pharmaceutics·Benjamin WuytsPatrick Augustijns
Apr 6, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Pau ArbósJuan M Irache
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·L Z BenetV J Wacher
Jun 6, 2000·Advanced Drug Delivery Reviews·J H Lin
Jun 6, 2000·Advanced Drug Delivery Reviews·X Li, W K Chan
Jun 6, 2000·Advanced Drug Delivery Reviews·G C Williams, P J Sinko
Jul 6, 2000·International Journal of Pharmaceutics·R Panchagnula, N S Thomas
Feb 15, 2002·Bioorganic & Medicinal Chemistry Letters·Yuan ChengJames R Tata
Aug 6, 2002·Bioorganic & Medicinal Chemistry Letters·Joseph L DuffyJames R Tata
Sep 25, 2002·Bioorganic & Medicinal Chemistry Letters·Subharekha RaghavanJames R Tata
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E R Jenny-Avital
Aug 19, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·Erdembileg AnuuradLars Berglund
Nov 12, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yongmei PanPeter W Swaan
Apr 22, 2009·The AAPS Journal·Masoud JameiGeoffrey Tucker
Mar 10, 2000·Clinical Pharmacokinetics·K VenkatakrishnanD J Greenblatt
Mar 24, 2000·Drugs·T C Roos, H F Merk
Jan 1, 2002·Clinical Drug Investigation·Charles E FrostGene D Morse
Dec 15, 2010·Drugs·Kay SedenDavid Back
Aug 12, 2009·Pharmacogenomics·Sukhwinder S LakhmanGene D Morse
Aug 29, 2014·Clinical Pharmacokinetics·Kajal B LarsonEdward P Acosta
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Mar 29, 2002·Journal of Pharmaceutical Sciences·Nobuhito ShibataKanji Takada
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Hiroshi KomuraYuichi Sugiyama
Nov 27, 2004·The Journal of Pharmacy and Pharmacology·Takashi MizumaMasahiro Hayashi
Jan 10, 2002·Journal of Pharmaceutical Sciences·Guanfa GanRonald J Sawchuk
Aug 30, 2007·The Journal of Pharmacy and Pharmacology·Mehrdad Hamidi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.